Investment Case

We are a leading aquaculture biotechnology company uniquely positioned to address the need for sustainable seafood production.

  • Crucial role in food security: >50% of fish consumption
  • Attractive expected growth for major species
  • Lower carbon footprint than other animal proteins
  • Demographic and health megatrends

32% increase in aquaculture production by 2030

Market leader in mission critical areas:

  • Salmon genetics
  • Early-stage specialist nutrition
  • Salmon sea lice treatments

We feed 1 in 3 shrimp produced globally

  • 3 complementary areas driving farming efficiency, sustainable production and animal health
  • High entry barriers
  • World-leading team of scientists
  • Track record of innovation and robust IP

20+ year genetics programmes

  • Consistent delivery following successful restructuring
  • At a financial turning point
  • New commercial and financial discipline in place
  • Financial framework to drive profitability and returns

132% revenue growth post-restructuring

  • Purpose driven, high quality organisation
  • Sustainability at core of our mission
  • On target to deliver on Net Zero commitment
  • First green loan and green bond issued in 2022
keyboard_arrow_up